Log in to save to my catalogue

Natalizumab in Crohn’s Disease: Results from a US tertiary IBD center

Natalizumab in Crohn’s Disease: Results from a US tertiary IBD center

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4779049

Natalizumab in Crohn’s Disease: Results from a US tertiary IBD center

About this item

Full title

Natalizumab in Crohn’s Disease: Results from a US tertiary IBD center

Journal title

Inflammatory bowel diseases, 2013-03, Vol.19 (3), p.621-626

Language

English

Formats

More information

Alternative Titles

Full title

Natalizumab in Crohn’s Disease: Results from a US tertiary IBD center

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4779049

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4779049

Other Identifiers

ISSN

1078-0998

E-ISSN

1536-4844

DOI

10.1097/MIB.0b013e31827eea78

How to access this item